Access

(redirected from Hemodialysis access)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.

Access

The ability or authority to view restricted data or enter a restricted area.
References in periodicals archive ?
Ash, MD, FACP, a world renowned thought leader in the field of hemodialysis access.
SAVE-2 will enroll up to 60 patients covering a broad landscape of hemodialysis access needs.
Control Medical is also planning to expand the ASPIRE platform into thrombus aspiration for heart attack, stroke, and hemodialysis access.
Peripheral Vascular Reconstructions Aorto-femoral bypass, aorto-iliac bypass, aortic bypass, aorto-innominate bypass, carotid bypass, carotid endarterectomy, femoral-distal bypass, femoral-femoral bypass, femoral-popliteal bypass, hepatic-renal bypass, popliteal-dorsalis pedis bypass, profunda endarterectomy, renal bypass, extremity bypass, renal endarterectomy, hemodialysis access, arteriovenous graft.
The clinical trials known as V-HEALTH (Vascular intimal Hyperplasia: Extending Arterial and venous patency, Limiting vascular Trauma, and inhibiting Hyperplasia while re-establishing vascular health) were designed to evaluate the safety of Vascugel([R])treatment in patients with ESRD undergoing placement of an AVG or AVF for hemodialysis access.
The CVP Summit will examine treatment strategies for durable hemodialysis access in cases of central venous pathology through an interactive, data-driven and clinically-focused didactic and hands-on wet lab practicum.
The current generation includes a standard ePTFE graft, which requires the placement of a temporary dialysis catheter for approximately 2-3 weeks until the graft incorporates into the surrounding tissue and can be used for hemodialysis access.
to repair and clear thrombosed hemodialysis access grafts and fistulae.
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists, and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, today highlighted results from a United States preliminary study of Centros[TM], a self-centering, tunneled hemodialysis access catheter.
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it launched Centros[TM], a self-centering, tunneled hemodialysis access catheter.